Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:05 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Logos Global Management LP | 150,000 0.400% |
150,000 (New Position) |
Filing History |
| 2022-02-14 1:36 pm Sale |
2021-12-31 | 13G | Nkarta, Inc. NKTX |
Logos Global Management LP | 0 0.000% |
-1,927,180 (Position Closed) |
Filing History |
| 2022-01-26 4:27 pm Sale |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Logos Global Management LP | 0 0.000% |
-1,339,793 (Position Closed) |
Filing History |
| 2021-12-27 5:25 pm Purchase |
2021-12-17 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 183,000 5.600% |
183,000 (New Position) |
Filing History |
| 2021-12-02 4:53 pm Purchase |
2021-11-22 | 13G | COMPASS Pathways plc CMPS |
Logos Global Management LP | 1,400,000 3.400% |
1,400,000 (New Position) |
Filing History |
| 2021-11-15 2:24 pm Purchase |
2021-11-01 | 13G | Atreca, Inc. BCEL |
Logos Global Management LP | 996,584 3.300% |
996,584 (New Position) |
Filing History |
| 2021-09-29 09:30 am Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Logos Global Management LP | 1,495,000 8.800% |
1,495,000 (New Position) |
Filing History |
| 2021-09-13 5:12 pm Unchanged |
2021-09-02 | 13G | Forte Biosciences, Inc. FBRX |
Logos Global Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-09-09 12:30 pm Purchase |
2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Logos Global Management LP | 1,339,793 9.400% |
1,339,793 (New Position) |
Filing History |
| 2021-08-16 2:37 pm Purchase |
2021-08-05 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 3,894,392 7.600% |
3,894,392 (New Position) |
Filing History |
| 2021-08-13 12:27 pm Purchase |
2021-08-03 | 13G | Aligos Therapeutics, Inc. ALGS |
Logos Global Management LP | 114,911 6.700% |
114,911 (New Position) |
Filing History |
| 2021-07-28 7:32 pm Purchase |
2021-07-19 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 1,500,000 6.200% |
1,500,000 (New Position) |
Filing History |
| 2021-07-28 6:52 pm Purchase |
2021-07-19 | 13G | Kezar Life Sciences, Inc. KZR |
Logos Global Management LP | 250,000 5.200% |
250,000 (New Position) |
Filing History |
| 2021-06-15 12:19 pm Purchase |
2021-06-14 | 13D | ALX Oncology Holdings Inc. ALXO |
Logos Global Management LP | 3,156,981 7.900% |
76,080 (+2.47%) |
Filing History |
| 2020-12-03 4:06 pm Purchase |
2020-11-23 | 13D | Olema Pharmaceuticals, Inc. OLMA |
Logos Global Management LP | 3,758,818 9.400% |
3,758,818 (New Position) |
Filing History |
| 2020-11-19 4:05 pm Purchase |
2020-11-09 | 13G | Cogent Biosciences, Inc. COGT |
Logos Global Management LP | 1,907,971 9.990% |
1,907,971 (New Position) |
Filing History |
| 2020-11-16 4:04 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Logos Global Management LP | 550,000 14.100% |
550,000 (New Position) |
Filing History |
| 2020-11-09 12:42 pm Purchase |
2020-10-29 | 13G | NOVUS THERAPEUTICS INC NVUS |
Logos Global Management LP | 224,071 15.700% |
224,071 (New Position) |
Filing History |
| 2020-11-09 12:26 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Logos Global Management LP | 6,000,000 8.800% |
6,000,000 (New Position) |
Filing History |
| 2020-10-22 12:27 pm Purchase |
2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX |
Logos Global Management LP | 1,700,000 4.300% |
1,700,000 (New Position) |
Filing History |